Insulinoma in a patient with Congenital adrenal hyperplasia

Andrew Boutsicaris1, Prathayini Subarajan2, Rod Marianne Arceo-Mendoza2
1Loyola University Medical Center, Department of Internal Medicine, USA
2Loyola University Medical Center, Department of Endocrinology and Metabolism, USA

Tài liệu tham khảo

Metz, 2008, Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors, Gastroenterology, 135, 1469, 10.1053/j.gastro.2008.05.047 Lee, 2019, Incidence trends of gastroenteropancreatic neuroendocrine tumors in the United States, Clin Gastroenterol Hepatol, 17, 2212, 10.1016/j.cgh.2018.12.017 Service, 1991, Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study, Mayo Cliu Proc, 66, 711, 10.1016/S0025-6196(12)62083-7 Jensen, 2012, ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes, Neuroendocrinology, 95, 98, 10.1159/000335591 Vinik, 2010, NANETS consensus guidelines for the diagnosis of neuroendocrine tumor, Pancreas, 39, 713, 10.1097/MPA.0b013e3181ebaffd Yang, 2021, Diagnostic performance of noninvasive imaging modalities for localization of insulinoma: a meta-analysis, Eur J Radiol, 145, 1, 10.1016/j.ejrad.2021.110016 Mehrabi, 2014, A systematic review of localization, surgical treatment options, and outcome of insulinoma, Pancreas, 43, 675, 10.1097/MPA.0000000000000110 Kunz, 2013, Consensus guidelines for the management and treatment of neuroendocrine tumors, Pancreas, 42, 557, 10.1097/MPA.0b013e31828e34a4 Agata, 2016, Glycemic control in patients with insulinoma, Hormones (Basel), 15, 489 Ferrer-Garcia, 2013, Management of malignant insulinoma, Clin Transl Oncol, 15, 725, 10.1007/s12094-012-0996-7 Novotny, 2005, Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinoma, Support Care Cancer, 13, 760, 10.1007/s00520-005-0840-5 Ong, 2010, Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma, Eur J Endocrinol, 162, 1001, 10.1530/EJE-09-1010 El-Maouche, 2017, Congenital adrenal hyperplasia, Lancet, 390, 2194, 10.1016/S0140-6736(17)31431-9 Witchel, 2017, Congenital adrenal hyperplasia, J Pediatr Adolesc Gynecol, 30, 520, 10.1016/j.jpag.2017.04.001 Speiser, 2018, Congenital adrenal hyperplasia due to steroid21-hydroxylase deficiency: an endocrine society* clinical practice guideline, J Clin Endocrinol Metabol, 103, 4043, 10.1210/jc.2018-01865 Cardenas, 2020, Unusual combination of MEN-1 and theContiguous gene deletion syndrome of CAH and ehlers-danlos syndrome (CAH-X), Journal of the Endocrine Society, 4, 1